187sek
-1,8 %
Date:2025-05-14Time:17:29:37Latest report:Q4-2024List:First NorthTicker:ALZ
Market Cap:195 msekEnterprise Value:179 msekNet Sales:0,03 msekEarnings:-20,6 msekEmployees:0ISIN:SE0007413455

Ratios

10-year key figure history for Alzinova turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Alzinova with index and moving average MA50 and MA200.

Stockprice:1,87
MA50:2,24
MA200:3,19
Price/MA200:-41,6 %
RSI (14):41,0
Price/MA50:-16,8 %

Description

Alzinova is a biotechnology company. The company specializes in the therapeutic treatment of Alzheimer's and conducts research and development of peptides that are further developed as vaccines. In addition, the company also develops various research tools in the work area. The largest operations are in the Nordic market. The company was founded in 2011 and is headquartered in Gothenburg.

Biotechnology